Treatment of interstitial cystitis
OwnerJerome Checkinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods of alleviating a symptom of chronic pelvic pain syndrome with an amphetamine. Specifically, the invention includes a method of administering dextroamphetamine or a salt thereof to an animal in order to treat interstitial cystitis, vulvovaginits and/or vulvodynia. The invention also includes a composition comprising an amphetamine and at least one agent including but not limited to an antibiotic, a dietary supplement, a taste enhancer, an antiinflammatory and/or and antihistamine.
Claims25
A method of alleviating at least one symptom of chronic pelvic pain syndrome, the method comprising administering an amphetamine in a therapeutically effective amount, wherein said amphetamine is not administered transdermally.
A method of alleviating at least one symptom of interstitial cystitis, vulvovaginitis and/or vulvodynia in an animal, the method comprising administering a therapeutically effective amount of dextroamphetamine or a salt thereof to the animal, wherein dextromethorphan or dextrophan are not administered to the animal and the dextroamphetamine or salt thereof is administered intravenously, vaginally, intracutaneously, systemically, orally or rectally.
A method of alleviating pain and urgency associated with interstitial cystitis, vulvovaginitis and/or vulvodynia in an animal, said method comprising:
- (a) diagnosing the interstitial cystitis, vulvovaginitis and/or vulvodynia by a method selected from the group consisting of laproscopy, cystoscopy, water load test and a patient score on a patient symptom scale;
- and
- (b) administering a therapeutically effective amount of amphetamine to the animal, thereby alleviating the pain and urgency associated with interstitial cystitis, vuvlvovaginitis and/or vulvodynia.
A composition comprising an amphetamine and at least one agent selected from the group consisting of an antibiotic, a dietary supplement, a fat supplement and an antihistamine, wherein the amphetamine is present in an amount effective to alleviate at least one symptom of chronic pelvic pain syndrome in an animal.
Dependencies are inferred from the claim text.